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Bannayan-Zonana syndrome; Riley-Smith 
syndrome; Ruvalcaba-Myhre-Smith syndrome; 
Macrocephaly, pseudopapilledema, multiple 
hemangiomata; Macrocephaly, multiple lipomas, 
hemangiomata 
Inheritance 
autosomal dominant; existence of sporadic cases. 
Clinics 
Note 
Bannayan-Riley-Ruvalcaba syndrome is an 
overgrowth syndrome/hamartomatous polyposis 
condition with an increased risk of benign and 
malignant tumours; other overgrowth syndromes at 
(known) risk of tumourigenesis are: 
- Beckwith-Weideman syndrome,  
- Sotos syndrome (cerebral gigantism),  
- Hemihyperplasia (hemihypertrophy), and  
- Simpson Golabi Behemel syndrome. 
Phenotype and clinics 
Onset in chilhood (in contrast with Cowden disease, 
although an allelic disorder, see below); more often 
found in male patients (lower penetrance in female 
patients). 
- Overgrowth at birth (postnatal growth 
decelerates). 
- Macrocephaly. 
- Hypotonia and mental deficiency. 
- Subcutaneous and visceral lipomas and 
hemangiomas, and intestinal juvenile polyposis. 
- Myopathy of the proximal type in 2/3 of cases. 
- Pigmentation spots of the male genitalia. 
Neoplastic risk 
- Multiple lipomas (75% of cases). 
- Hemangiomas (40%). 
- Hamartomatous polyps (ileus and colon; 45%). 
- Lymphangiomas (10%). 






Description: 403 amino acids. 
Function: Protein tyrosine phosphatase; tumour 
suppressor gene. 
Mutations 
Germinal: May be not all Bannayan-Riley-
Ruvalcaba syndrome cases are due to PTEN 
mutations; germ-line mutations have also been 
described in Cowden disease and in some cases 
with juvenile polyposis syndrome. 
Somatic: PTEN is mutated in a large number of 
cancer types. 
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